Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin 2017; 27(01): 35-44
DOI: 10.1055/s-0042-120121
Wissenschaft und Forschung
© Georg Thieme Verlag KG Stuttgart · New York

Untersuchung der Wirksamkeit biomechanischer Stimulationstherapie bei Fibromyalgie-Syndrom

Evaluation of the Efficacy of Biomechanical Stimulation Therapy in Fibromyalgia Syndrome
Stefan Cebulla
1   Dermatologie und Allergologie, Universitätsklinikum Gießen und Marburg Standort Gießen, Gießen
,
Uwe Lange
2   Department of Rheumatology, Osteology and Physical Medicine, Kerckhoff-Klinik, University Gießen, Bad Nauheim
,
Ulf Müller-Ladner
3   Rheumatology, Osteology and Physical Medicine, Kerckhoff-Klinik, Bad Nauheim
,
Ingo H. Tarner
3   Rheumatology, Osteology and Physical Medicine, Kerckhoff-Klinik, Bad Nauheim
› Author Affiliations
Further Information

Publication History

eingereicht  18 June 2016

angenommen 27 October 2016

Publication Date:
12 April 2017 (online)

Zusammenfassung

Fragestellung:

Untersucht wurde die Wirksamkeit der biomechanischen Stimulationstherapie (BMS) bei Fibromyalgie-Syndrom (FMS).

Methode:

15 Probanden erhielten eine BMS der tender points im Bereich der Humerusepikondylen über 6 Wochen 3-mal pro Woche für je 20 min, 13 Probanden eine Scheinbehandlung mit abgekoppelter BMS-Sonde nach gleichem Schema. Untersucht wurden lokaler und globaler Schmerz mittels visueller Analogskala, Muskelkraft der an den Humerusepikondylen inserierenden Muskelgruppen mittels Muskelfunktionstests sowie Lebensqualität und globale körperliche Funktion mittels fibromyalgia impact questionnaire und FIBRO change scale.

Ergebnisse:

Für keinen der untersuchten Parameter wurde am Ende der Behandlungsphase sowie 12 Wochen danach eine signifikante Veränderung festgestellt.

Schlussfolgerung:

Eine BMS der tender points scheint trotz guter Verträglichkeit wenig geeignet, die lokalen oder globalen Beschwerden und die körperliche Funktion bei FMS-Patienten positiv zu beeinflussen.

Abstract

Purpose:

We evaluated the efficacy of biomechanical stimulation therapy (BMS) in fibromyalgia syndrome (FMS).

Methods:

15 participants received 20 min of BMS therapy of the tender points near the humeral epicondyles 3 times a week for 6 weeks, 13 participants received a sham treatment with a disconnected probe according to the same scheme. We evaluated local and global pain by visual analogue scale, muscular strength of the muscle groups inserting at the epicondyli by means of muscle function tests as well as quality of life and physical functioning by fibromyalgia impact questionnaire and FIBRO change scale.

Results:

Both after 6 weeks of treatment and at the end of a 12-week follow-up period there were no significant changes within and between the treatment groups.

Conclusions:

It can be concluded that although BMS of tender points is well tolerated, it is not suited for improving local or global symptoms and physical function in FMS patients.

 
  • Literatur

  • 1 Wolfe F, Smythe HA, Yunus MB. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990 33: 160-172
  • 2 Wolfe F, Clauw DJ, Fitzcharles MA. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010; 62: 600-610
  • 3 Atzeni F, Salaffi F, Bazzichi L. et al. The evaluation of the fibromyalgia patients. Reumatismo 2008; 60 (Suppl. 01) 36-49
  • 4 Fitzcharles MA, Yunus MB. The clinical concept of fibromyalgia as a changing paradigm in the past 20 years. Pain Res Treat 2012; 2012: 184835
  • 5 Staud R, Rodriguez ME. Mechanisms of disease: pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol 2006; 2: 90-98
  • 6 Cassisi G, Sarzi-Puttini P, Alciati A. et al. Symptoms and signs in fibromyalgia syndrome. Reumatismo 2008; 60 (Suppl. 01) 15-24
  • 7 White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep 2001; 5: 320-329
  • 8 Eich W, Häuser W, Friedel E. et al. Themenheft Fibromyalgiesyndrom – Interdisziplinäre S3-Leitlinie. Definition, Pathophysiologie, Diagnostik und Therapie des Fibromyalgiesyndroms. Schmerz 2008; 22: 255-266
  • 9 Langhorst J, Häuser W, Bernardy K. et al. Themenheft Fibromyalgiesyndrom – Eine interdisziplinäre S3-Leitlinie. Hintergründe und Ziele – Methodenreport – Klassifikation – Pathophysiologie – Behandlungsgrundsätze und verschiedene Therapieverfahren. Schmerz 2012; 26: 311-317
  • 10 Vierck Jr CJ. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 2006; 124: 242-263
  • 11 Staud R. Treatment of fibromyalgia and its symptoms. Expert Opin Pharmacother 2007; 8: 1629-1642
  • 12 Stisi S, Cazzola M, Buskila D. et al. Etiopathogenetic mechanisms of fibromyalgia syndrome. Reumatismo 2008; 60 (Suppl. 01) 25-35
  • 13 Collado-Mateo D, Adsuar JC, Olivares PR. et al. Effects of Whole-Body Vibration Therapy in Patients with Fibromyalgia: A Systematic Literature Review. Evid Based Complement Alternat Med 2015; 2015: 719082
  • 14 Klyscz T. et al. Biomechanical stimulation therapy as physical treatment of arthrogenic venous insufficiency. Hautarzt 1997; 48: 318-322
  • 15 Fox EL, Matthew DK. The physiological basis of physical education and athletics. Saunders,CBC College Publishing, : Philadelphia; 1981: 293-393
  • 16 Lundeberg T, Nordemar R, Ottoson D. Pain alleviation by vibratory stimulation. Pain 1984; 20: 25-44
  • 17 Klyscz T, Ritter-Schempp C, Jünger M. et al. Biomechanical stimulation therapy. A novel physiotherapy method for systemic sclerosis. Adv Exp Med Biol 1999; 455: 309-316
  • 18 Berg W, Tarner IH, Riemekasten G. et al. Biomechanical stimulation therapy – an efficacious method for facial scleroderma with reduced oral aperture. J Rheum Dis Treat 2016; 2: 030
  • 19 Issurin VB, Liebermann DG, Tenenbaum G. Effect of vibratory stimulation training on maximal force and flexibility. J Sports Sci 1994; 12: 561-566
  • 20 Boomershine CS. A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity. Pain Res Treat 2012; 2012: 653714
  • 21 Bennett RM, Friend R, Jones KD. et al. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009; 11: R120
  • 22 Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23 (Suppl. 39) 154-162
  • 23 Boomershine CS. The FIBRO System: a rapid strategy for assessment and management of fibromyalgia syndrome. Ther Adv Musculoskel Dis 2011; 3: 215-226
  • 24 Nampiaparampil DE, Shmerling RH. A review of fibromyalgia. Am J Manag Care 2004; 10 11 Pt 1 794-800